Status:
NOT_YET_RECRUITING
Serum Preptin Level and Its Relationship with Bone Mineral Disease in Chronic Kidney Disease Patients
Lead Sponsor:
Assiut University
Conditions:
Preptin
Eligibility:
All Genders
18-50 years
Brief Summary
Aim of the research:To identify preptin level and relationship with bone disease in chronic kidney disease patients.
Detailed Description
Preptin is a 34-aminoacid peptide derived from the E-peptide of pro-insulin-like growth factor 2 (pro-IGF2) that is co-secreted with insulin and upregulates glucose-mediated insulin secretion. High se...
Eligibility Criteria
Inclusion
- both sex groups of patients with age between 18-50 years . pre end stage renal disease and end stage renal disease patients .
Exclusion
- type 2 diabetic patients
Key Trial Info
Start Date :
June 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2026
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06594042
Start Date
June 1 2025
End Date
September 1 2026
Last Update
September 23 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.